Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Saved in:
Bibliographic Details
Title: Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.
Authors: Eldesouki MH; Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA., Ibrahim A; Division of Gastroenterology & Hepatology, Medical University of South Carolina, Charleston, South Carolina, USA., Marey MM; Department of Internal Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Francis FF; Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida, USA., Alsakarneh S; Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Ayala E; Division of Haematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA., Shaukat A; Division of Gastroenterology and Hepatology, NYU Grossman School of Medicine, NYU Langone Health, New York, New York, USA., Farraye FA; Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida, USA., Hashash JG; Division of Gastroenterology & Hepatology, Mayo Clinic, Jacksonville, Florida, USA.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Jul 03. Date of Electronic Publication: 2026 Jul 03.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2036
DOI:10.1111/apt.70779